Two of the four dossier assessments that were published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 2 July 2018, and which deal with completely different therapeutic ...

Oxford-based biotechnology group Summit plc has kicked off a Phase II trial investigating the potential of its lead drug candidate SMT D001 as a treatment of sialorrhoea. Oxford-based biotechnology ...

Regulatory status: new medicine. Glycopyrronium bromide (Sialanar) is an antimuscarinic (anticholinergic) medicine licensed in September 2016 for the symptomatic treatment of severe sialorrhoea ...

A literature search was conducted which identified 62 references (see search strategy for full details). These references were screened using their titles and abstracts and 11 references were obtained ...